35 filings
Page 2 of 2
8-K
j8bhsvoa fx39a
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
g2lt1ys
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
12zkfds610u
20 Sep 22
Departure of Directors or Certain Officers
5:14pm
8-K
p7w70lkadtvuqgxchdjs
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
8-K
9ir9ki8kism vx1q
14 Jul 22
Departure of Directors or Certain Officers
5:13pm
8-K
2l6wwbmf
10 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
eltgunw
11 May 22
Absci Reports First Quarter 2022 Financial and Operating Results
8:15am
8-K
8658xuyr68n
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
udjg4 gunf4a
21 Mar 22
Departure of Directors or Certain Officers
4:20pm
8-K
awdxlkhvxzz317eg
10 Jan 22
Departure of Directors or Certain Officers
8:58am
8-K
pyk0zop mdq
7 Jan 22
Absci Announces Research Collaboration with Merck
8:53am
8-K
th5lsq8tbxojzawq53bt
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am
8-K
m4cw5
7 Sep 21
Absci Reports Second Quarter 2021 Financial and Operating Results
8:40am
8-K
jusvvms x8ze8znyyybs
24 Aug 21
Departure of Directors or Certain Officers
9:03am
8-K
8v3x8bff01ak
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm